Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133562) titled 'Efficacy of Vunakizumab in Patients with Moderate-to-Severe Plaque Psoriasis and Obesity: A Single-Center, Prospective Clinical Study' on Sept. 29.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shenzhen Second People's Hospital
Condition:
Moderate-to-severe plaque psoriasis (psoriasis vulgaris) in patients with obesity
Intervention:
Non-obesity Group:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Non-obesity Group:60;Obesity Group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org....